GlobalData's clinical trial report, "Choledocholithiasis Global Clinical Trials Review, H1, 2012" provides data on the Choledocholithiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Choledocholithiasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Choledocholithiasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Choledocholithiasis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Choledocholithiasis , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
TOC
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Choledocholithiasis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Nations 14
Clinical Trials in G7 Nations by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Unaccomplished Trials of Choledocholithiasis 19
Subjects Recruited Over a Period of Time 20
Prominent Sponsors 21
Prominent Drug Comparison 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Universities / Institutes / Hospitals 24
National Taiwan University Hospital 24
Clinical Trial Overview of National Taiwan University Hospital 24
Sydney West Area Health Service 25
Clinical Trial Overview of Sydney West Area Health Service 25
Cornell University 26
Clinical Trial Overview of Cornell University 26
Hvidovre University Hospital 27
Clinical Trial Overview of Hvidovre University Hospital 27
Soonchunhyang University Hospital 28
Clinical Trial Overview of Soonchunhyang University Hospital 28
University of Yamanashi. 29
Clinical Trial Overview of University of Yamanashi. 29
Istanbul University 30
Clinical Trial Overview of Istanbul University 30
Arak University of Medical Sciences 31
Clinical Trial Overview of Arak University of Medical Sciences 31
St John of God Health Care 32
Clinical Trial Overview of St John of God Health Care 32
University of Thessaly 33
Clinical Trial Overview of University of Thessaly 33
Stanford University 34
Clinical Trial Overview of Stanford University 34
University of Florida 35
Clinical Trial Overview of University of Florida 35
Five Key Clinical Profiles 36
Appendix 51
Abbreviations 51
Definitions 51
Research Methodology 52
Secondary Research 52
About GlobalData 53
Contact Us 53
Disclaimer 53
Source 54
List of Tables
List of Tables
Choledocholithiasis Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7
Choledocholithiasis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Choledocholithiasis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Choledocholithiasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10
Choledocholithiasis Therapeutics Clinical Trials, Europe, Top Countries, 2012* 11
Choledocholithiasis Therapeutics Clinical Trials, North America, Top Countries, 2012* 12
Choledocholithiasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13
China Pharmaceutical Guidebook Series (3) 2013 - Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Biological Products
